Variability in Clinical Performance of the FDA-Cleared Lumipulse P-Tau217/beta-Amyloid 1-42 Plasma Ratio. Algeciras-Schimnich A, Bornhorst JA, Figdore DJ, Rea Reyes RE, et al. JAMA Neurol 2026 Jun 1:e261565. doi: 10.1001/jamaneurol.2026.1565.

Read + Share

Amedeo Smart

Independent Medical Education

Algeciras-Schimnich A, Bornhorst JA, Figdore DJ, Rea Reyes RE, et al. Variability in Clinical Performance of the FDA-Cleared Lumipulse P-Tau217/beta-Amyloid 1-42 Plasma Ratio. JAMA Neurol 2026 Jun 1:e261565. doi: 10.1001/jamaneurol.2026.1565.
PMID: 42223932